Kadcyla Trastuzumab Emtansene 160mg

100,000.00

KADCYLA is a prescription medicine used to treat HER2-positive breast cancer that has spread to other parts of the body (metastatic breast cancer) after prior treatment with trastuzumab (Herceptin®) and a taxane.

Product Details:

Manufacturer Roche
Packaging Size 1’s
Brand Kadcyla
Composition Trastuzumab Emtashine 160mg
Prescription/Non prescription Prescription
Manufactured By Roche
Form Injection
Product Name Kadcyla
Marketed By Roche
Therapeutic Uses A drug used to treat certain patients with HER2-positive breast cancer that has already been treated
Treatment A drug used to treat certain patients with HER2-positive breast cancer that has already been treated

Reviews

There are no reviews yet.

Be the first to review “Kadcyla Trastuzumab Emtansene 160mg”

Your email address will not be published. Required fields are marked *

Shopping Cart